title: [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
abstract: Human papillomavirus (HPV) infection is the central cause of invasive cervical cancer (ICC) and its precursor lesions. Both vaccines can prevent most cases of cervical cancer. In addition, both can prevent vaginal and vulvar cancer in women, and HPV-related cancers. HPV4 can prevent genital warts in women and men. Routine vaccination of 12-year-old girls with HPV4 vaccine appears to be cost-effective in addition to providing both short-term and long-term health gains.
authors.forename: M
authors.initials: M
authors.lastname: Malinova
mesh_terms: D000293:Adolescent; D003218:Condylomata Acuminata / Q000517:prevention & control; D005260:Female; D006801:Humans; D008297:Male; D030361:Papillomavirus Infections / Q000150:complications / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000191:economics / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination; D014625:Vaginal Neoplasms / Q000209:etiology / Q000517:prevention & control / Q000821:virology; D014846:Vulvar Neoplasms / Q000209:etiology / Q000517:prevention & control / Q000821:virology
chemical_list: D053918:Papillomavirus Vaccines